+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus)



Evaluation of a microparticle enzyme immunoassay for the measurement of sirolimus in whole blood (Abbott IMx sirolimus)



Clinical Laboratory 52(7-8): 325-334



An immunoassay of sirolimus based on the microparticle enzyme immunoassay (MEIA) principle was evaluated on 105 whole blood samples (EDTA) drawn from a population of renal (n = 38) and hepatic or heart (n = 3) transplant patients. Each blood sample was analyzed simultaneously by MEIA and by a liquid chromatography mass spectrometry (LC-MS) method. The statistical analysis according to Passing-Bablok (x= LCMS, y= mean of two measurements of the same samples on IMx) produced the following results: Spearman r value = 0.9651, y(MEIA) = 0.99x (LCMS) - 0.26 microg/l. The analytical performance of the MEIA method showed a CV < or = 10% and a lower limit of quantification of 1.5 microg/l, which are acceptable for routine clinical monitoring. In conclusion, the MEIA method has shown robust, stable and reproducible features with an excellent correlation with the LC-MS method.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 048993530

Download citation: RISBibTeXText

PMID: 16955630


Related references

Determination of everolimus in whole blood using the Abbott IMx sirolimus microparticle enzyme immunoassay. Clinical Biochemistry 40(1-2): 132-136, 2007

Multi-site analytical evaluation of a chemiluminescent magnetic microparticle immunoassay (CMIA) for sirolimus on the Abbott ARCHITECT analyzer. Clinical Biochemistry 42(15): 1543-1548, 2009

Multi-Center Evaluation Of An Immunoassay For The Measurement Of Sirolimus On The Abbott Imx Analyzer. Transplantation Journal 78: 477-478, 2004

Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. Clinical Biochemistry 39(4): 378-386, 2006

Comparison of high-resolution liquid chromatography versus microparticle enzyme immunoassay for the measurement of sirolimus levels in renal transplantation. Farmacia Hospitalaria 30(3): 142-148, 2006

Analytical performance of microparticle enzyme immunoassay and HPLC-tandem mass spectrometry in the determination of sirolimus in whole blood. Clinical Chemistry 45(12): 2278-2280, 1999

Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method. Upsala Journal of Medical Sciences 114(1): 55-61, 2009

A microparticle enzyme immunoassay to measure sirolimus. Transplantation Proceedings 37(1): 182-184, 2005

Evaluation of the Abbott ARCHITECT i2000 sirolimus assay and comparison with the Abbott IMx sirolimus assay and an established liquid chromatography-tandem mass spectrometry method. Therapeutic Drug Monitoring 33(4): 453-459, 2011

Relationship between everolimus blood concentration assessed using the Innofluor Certican Fluorescence Polarization Immunoassay and the Architect i System sirolimus chemiluminescent microparticle immunoassay. Transplantation Proceedings 42(5): 1867-1869, 2010

Evaluation of an immunoassay (Abbott-IMX Analyzer) allowing routine determination of sirolimus: comparison with LC-MS method. Transplantation Proceedings 38(7): 2352-2353, 2006

The quantification of sirolimus by high-performance liquid chromatography-tandem mass spectrometry and microparticle enzyme immunoassay in renal transplant recipients. Clinical Therapeutics 22(Suppl. B): B71-B85, 2000

Measurement of sirolimus concentrations in human blood using an automated electrochemiluminescence immunoassay (ECLIA): a multicenter evaluation. Clinical Chemistry and Laboratory Medicine 56(5): 764-775, 2018

Evaluation of the Abbott IMx hepatitis B surface antigen microparticle enzyme immunoassay. Clinical Chemistry 43(6 Part 2): S248-S249, 1997

Evaluation of the Abbott AxSYM total Beta-HCG microparticle enzyme immunoassay. Clinical Chemistry 42(6 Part 2): S119, 1996